The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study

Idilman, I.; Celik, A.; Savas, B.; Idilman, R.; Karcaaltincaba, M.

doi:10.1016/j.crad.2021.06.014

The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study

Copy For Citation

Idilman I. S. , Celik A., Savas B., Idilman R., Karcaaltincaba M.

CLINICAL RADIOLOGY, vol.76, no.9, 2021 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 76 Issue: 9
Publication Date: 2021
Doi Number: 10.1016/j.crad.2021.06.014
Title of Journal : CLINICAL RADIOLOGY

Abstract

AIM: To determine the feasibility of magnetic resonance imaging T2 mapping in the quantification of liver steatosis in patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD), and to assess the effect of inflammation and fibrosis on T2 values of the liver.